▎药明康德内容团队编辑CartesianTherapeutics今日公布其在研mRNA细胞疗法Descartes-08在治疗全身性重症肌无力（MG）患者2b期试验中的最新疗效和安全性数据。分析显示，80%的可评估患者维持了临床显著应答达1年。详细数据 ...

The Southern Hemisphere's only mRNA manufacturing facility has opened in Victoria - backed by the Australian and Victorian Governments - ensuring ...

Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

“作为中国科学院与浙江省央地共建的国家级科研机构，杭州医学所不仅是中国科学院首个以医学命名的直属研究所，也是浙江省倾力打造的‘一三五’科创高地主平台之一，拥有与浙江省肿瘤医院深度融合发展的新型体制机制。”杭州医学所党委书记、副所长高军在接受《中国科学报》采访时介绍道。

Edwin Stone, Bernard Sagaert, and Khaled Yamout go behind the headlines to discuss what the ongoing measles outbreak in the ...

Moderna's (NASDAQ:MRNA) mRNA-1647, its vaccine asset for cytomegalovirus (CMV), may not yield positive interim phase 3 data ...

Cartesian Therapeutics reported longer-term results from a mid-stage study of its mRNA CAR-T therapy for myasthenia gravis, ...

Leerink analyst warned that Moderna (NASDAQ:MRNA) shares could fall more than 30% if interim results from its Phase 3 CMV ...

MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, announced ...

Australia’s first ever mRNA vaccine manufacturing facility is now operational in Melbourne, with locally made Moderna jabs ...

Commercial scale mRNA vaccines will be produced onshore for the first time in Australia with the opening of US pharma company ...

此外，曲凤宏还分享了干细胞再生疗法治疗1型糖尿病的案例，以及HPV疫苗在预防宫颈癌方面的显著效果。同时，他还介绍了mRNA技术发展历程，mRNA疫苗带动了一场新技术革命，与DNA相比，mRNA不稳定且容易诱发人体免疫反应。然而，随着RNP包裹技术的成 ...